rs200963884
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000112.4(SLC26A2):c.700-1G>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000112.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A2 | NM_000112.4 | c.700-1G>C | splice_acceptor_variant, intron_variant | Intron 2 of 2 | ENST00000286298.5 | NP_000103.2 | ||
SLC26A2 | XM_017009191.3 | c.700-1G>C | splice_acceptor_variant, intron_variant | Intron 2 of 3 | XP_016864680.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A2 | ENST00000286298.5 | c.700-1G>C | splice_acceptor_variant, intron_variant | Intron 2 of 2 | 1 | NM_000112.4 | ENSP00000286298.4 | |||
SLC26A2 | ENST00000503336.1 | c.372+1941G>C | intron_variant | Intron 1 of 1 | 3 | ENSP00000426053.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152192Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460574Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726736
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358
ClinVar
Submissions by phenotype
Diastrophic dysplasia;C0265274:Achondrogenesis, type IB;C1847593:Multiple epiphyseal dysplasia type 4;C1850554:Atelosteogenesis type II Pathogenic:2
This sequence change affects an acceptor splice site in intron 2 of the SLC26A2 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with diastrophic dysplasia (PMID: 7923357, 21155763; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.727-1G>C. ClinVar contains an entry for this variant (Variation ID: 56027). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Multiple epiphyseal dysplasia type 4 Pathogenic:1
- -
Achondrogenesis, type IB Pathogenic:1
- -
Diastrophic dysplasia Pathogenic:1
- -
Osteochondrodysplasia Pathogenic:1
Variant summary: SLC26A2 c.700-1G>C (also described as c.727-1G>C in the literature) is located in the canonical splice-site of the last intron and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of SLC26A2 function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 3 acceptor site. Four predict the variant creates a 3 acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251216 control chromosomes (gnomAD). c.700-1G>C has been reported in the literature in individuals affected with sulfate transporter-related osteochondrodysplasia (examples: Barbosa_2011, Hastbacka_1994, Silveira_2022). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 21155763, 11241838, 7923357, 34064542, 36660027). ClinVar contains an entry for this variant (Variation ID: 56027). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at